PixCell Medical, maker of a rapid diagnostic product, announced that NSW Pathology, the provider of public pathology services for the New South Wales (NSW) government, will deploy PixCell’s HemoScreen ...
YOKNEAM ILIT, Israel, Feb. 23, 2021 /PRNewswire/ -- PixCell Medical, innovator of rapid diagnostic solutions at the point-of-care, announced today that the Risk Underlying Rural Areas Longitudinal ...
YOKNEAM ILLIT, Israel, Aug. 23, 2023 /PRNewswire/ -- PixCell Medical, an innovator of rapid hematology testing solutions at the point of care (POC), is pleased to announce that the U.S. Food and Drug ...
Clinics, urgent care centers, busy hospitals, and patients can count on Hemoscreen, a miniaturized point-of-care hematology analyzer made by Pixcell Medical Technologies Ltd., to provide accurate ...
YOKNEAM ILLIT, Israel, Nov. 29, 2023 /PRNewswire/ -- A groundbreaking study conducted by a University of North Carolina (UNC) research team has unveiled compelling evidence supporting the adoption of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results